Shares of NeuroMetrix, Inc. (NURO) are climbing over 18 percent on Friday morning after the healthcare company announced steps to enhance shareholder value.
As part of the move, the company has appointed Joshua Horowitz as a new independent director for one year, and terminated its at-the-market equity...
Progress Software Corp. (PRGS), Friday announced a possible offer to acquire shares of cloud database company MariaDB for $0.60 per share in cash, valuing the entire issued capital at around $40.6 million.
Additionally, the offer includes a premium of 9 percent to the possible offer made by K1 Capital,...
Norfolk Southern Corporation (NSC) said Ancora Alternatives LLC has resorted to spreading false and misleading statements and deliberately ignoring material facts. Norfolk Southern noted that it has filed a presentation with the SEC addressing the flawed assumptions of Ancora Alternatives LLC's unrealistic...
Merck & Co Inc. (MRK) on Friday said its Keytruda in combination with fluoropyrimidine- and platinum-containing-chemotherapy has been approved by Health Canada for the treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma in adults.
This approval is based on results from the Phase...
Roche (RHHBY) announced the FDA has approved Alecensa for adjuvant treatment following tumour resection for patients with anaplastic lymphoma kinase-positive non-small cell lung cancer. The company said Alecensa is now the first and only ALK inhibitor approved for people with ALK-positive early-stage...
SK Telecom (SKM) announced a collaboration with Aptos Labs, Brevan Howard, and Microsoft to introduce Aptos Ascend, a comprehensive suite of institutional solutions for the global financial market.
The partnership integrates SKT's Wallet-as-a-Service product and the secure Aptos blockchain to deliver...
Histogen Inc. (HSTO), a drug development company for treatment of bacterial skin infections, said that it has filed voluntary petitions for relief under subchapter V of Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Southern District of California to confirm a plan...
Primerica Inc. (PRI), a financial services provider across the United States and Canada, has responded to a recent blog post containing false claims aimed at lowering the company's stock price.
The company asserts that the blog's assertions misrepresent Primerica's commitment to assisting middle-income...
Nordstrom Inc.'s (JWN) founding family has notified the board of its interest in taking the company private. The company formed a special committee to evaluate any proposal from the company's Chief Executive Officer Erik Nordstrom and the company's president Pete Nordstrom, and any proposals from other...
Genentech, a member of the Roche Group (RHHBY), said that the U.S. Food and Drug Administration has approved Alecensa (alectinib) for adjuvant treatment following tumor resection for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer or NSCLC (tumors 4 cm or node positive),...
Takeda (TAK) said that the U.S. Food and Drug Administration has approved Entyvio (vedolizumab) subcutaneous administration for maintenance therapy in adults with moderately to severely active Crohn's disease after induction therapy with intravenous (IV) Entyvio.
The subcutaneous administration of...
Assurant, Inc. (AIZ), Thursday announced a partnership with Lloyds Banking Group (LLOY) to offer mobile and device trade-in services to the customers of Lloyds Bank, Halifax and Bank of Scotland via online.
Under the agreement, customers will be provided a safe way to dispose old and unwanted devices...
Snacks manufacturer, Utz Brands, Inc. (UTZ), Thursday announced that its certain subsidiaries have agreed to sell two manufacturing units located at Berlin, PA, and Fitchburg, MA, to Our Home for $18.5 million.
Under the agreement, both the companies will manufacture certain Utz Brands products for...
Auto giant General Motors Co. (GM), Thursday announced the launch of vehicle-to-home or V2H bidirectional charging technology for residential customers, providing power from a compatible GM EV to their homes.
Initially, V2H bundle will consist of necessary equipment to enable the transfer of energy...
Actinium Pharmaceuticals, Inc. (ATNM) announced Thursday that results from the Phase 3 SIERRA trial of Iomab-B were presented in an oral presentation at the 50th Annual European Bone Marrow Transplant Society Meeting (EBMT) held in Glasgow, Scotland on April 14-17.
The results showed that an Iomab-B...